21162 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA Animal cells
Sub-classes:METHOD FOR PRODUCING LOW-ANTIGENIC CELL
#2TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS
#3VACCINE COMPRISING PERIPHERAL BLOOD MONONUCLEAR CELLS LOADED WITH NATURAL KILLER T CELL LIGAND AND ANTIGEN
#4CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#5METHODS
#6EPITOPE FOCUSING BY VARIABLE EFFECTIVE ANTIGEN SURFACE CONCENTRATION
#7BACILLUS CALMETTE-GUERIN (BCG) AND ANTIGEN PRESENTING CELLS FOR TREATMENT OF BLADDER CANCER
#8PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
#9Synergistic Inhibition of eIF5A and Notch Signaling in Intermediate Tregs
#10DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#11SMALLPOX VACCINE FOR CANCER TREATMENT
#12Bacillus Calmette-Guerin (BCG) and antigen presenting cells for treatment of bladder cancer
#13MESENCHYMAL STEM CELLS AS VACCINE ADJUVANTS AND METHODS FOR USING THE SAME
#14IMMUNOGENIC COMPOSITION
#15METHODS FOR EXPANSION OR DEPLETION OF T-REGULATORY CELLS
#16BETA-2 MICROGLOBULIN-DEFICIENT CELLS
#17ORAL VACCINE COMPOSITION
#18Bacillus Calmette-Guerin (BCG) and antigen presenting cells for treatment of bladder cancer
#19UNIVERSAL MAMMALIAN INFLUENZA VACCINE
#20METHODS AND COMPOSITIONS FOR TREATING CANCERS
#21Epitope focusing by variable effective antigen surface concentration
#22Compositions and Methods Related to Multimodal Therapeutic Cell Systems for Cancer Indications
#23METHODS AND COMPOSITIONS FOR DOSING IN ADOPTIVE CELL THERAPY
#24CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#25TRANSDUCED T CELLS EXPRESSING HUMAN SSTR2 AND APPLICATION THEREOF
#26T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#27PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
#28Bacillus Calmette-Guerin (BCG) and antigen presenting cells for treatment of bladder cancer
#29Smallpox vaccine for cancer treatment
#30PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
#31Methods
#32Methods
#33Method for depleting malignant T-cells
#34Method for depleting malignant T-cells
#35Combined organ and hematopoietic cells for transplantation tolerance of grafts
#36Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
#37Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
#38MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF
#39TARGET PEPTIDES FOR OVARIAN CANCER THERAPY AND DIAGNOSTICS
#40Platform for generating safe cell therapeutics
#41Platform for generating safe cell therapeutics
#42METHOD FOR LARGE-SCALE PRODUCTION OF ALLOSPECIFIC TYPE 1 REGULATORY TREGS (TR1) STABLE IN THE PRESENCE OF PROINFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#4314-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
#44Compositions and Methods Related to Multimodal Therapeutic Cell Systems for Autoimmune Indications
#45METHODS FOR PROFILING THE T-CEL- RECEPTOR REPERTOIRE
#46I DOMAIN CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO ICAM-1
#47METHODS AND COMPOSITIONS FOR TREATING CANCERS
#48Combined organ and hematopoietic cells for transplantation tolerance of grafts
#49Platform for generating safe cell therapeutics
#50Platform for generating safe cell therapeutics
#51Immunostimulatory compositions, particles, and uses related thereto
#52Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#53METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA
#54Epitope focusing by variable effective antigen surface concentration
#55Smallpox vaccine for cancer treatment
#56Therapeutic pooled blood apoptotic cell preparations and uses thereof
#57Methods and compositions for treating cancers
#58Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment
#59SHARED NEOANTIGENS
#60Methods for expansion or depletion of T-regulatory cells
#61Platform for generating safe cell therapeutics
#62Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#63ANTI-TLR4 ANTIBODIES AND USES THEREOF
#64PEPTIDIC CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF
#65Transduced T cells expressing human SSTR2 and application thereof
#66COMPOSITIONS AND METHODS RELATED TO ENGINEERED ERYTHROID CELLS COMPRISING IL-15
#67Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#68Methods and compositions for dosing in adoptive cell therapy
#69IL-12 IMMUNOTHERAPY FOR CANCER
#70I domain chimeric antigen receptor specific to ICAM-1
#71Methods related to engineered erythoid cells comprising 4-1BBL
#72Methods of treatment using conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses
#73Beta-2 microglobulin-deficient cells
#74Epitope focusing by variable effective antigen surface concentration
#75Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
#76Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion
#77Combined organ and hematopoietic cells for transplantation tolerance of grafts
#78Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#79METHODS AND COMPOSITIONS FOR VACCINATING AND BOOSTING CANCER PATIENTS
#80Combined organ and hematopoietic cells for transplantation tolerance of grafts
#81Combination therapy for a stable and long term engraftment
#82Universal mammalian influenza vaccine
#83Combined organ and hematopoietic cells for transplantation tolerance of grafts
#84Methods and systems for augmenting immune system responses
#85Placental Based Contraceptive Vaccine
#86Combined organ and hematopoietic cells for transplantation tolerance of grafts
#87Combined organ and hematopoietic cells for transplantation tolerance of grafts
#88Combined organ and hematopoietic cells for transplantation tolerance of grafts
#89Compositions and methods related to multimodal therapeutic cancer indications
#90Combined organ and hematopoietic cells for transplantation tolerance of grafts
#91Compositions and methods useful in treating Stargardt's disease and other ocular disorders
#92Methods and compositions for the treatment of melanoma
#93Mesenchymal stem cells as vaccine adjuvants and methods for using the same
#94Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#95Combined organ and hematopoietic cells for transplantation tolerance of grafts
#96Compositions and methods for modulating an immune response
#97Smallpox vaccine for cancer treatment
#98POTENTIATED T-CELL MODULATOR ABLE TO MODULATE IMMUNE RESPONSE, SPECIFICALLY DESIGNED FOR THERAPEUTIC USE AS A POTENTIATING ADJUVANT IN VIRUS VACCINES
#99Replacement of cytotoxic preconditioning before cellular immunotherapy
#100Toxicity management for anti-tumor activity of CARs
#101Toxicity management for anti-tumor activity of CARs
#102Identification of CD8T cells that are CD161and/or IL18R(α)and have rapid drug efflux capacity
#103Combined organ and hematopoietic cells for transplantation tolerance of grafts
#104CD127 expression inversely correlates with FoxP3 and suppressive function of CD4 Tregs
#105Epitope focusing by variable effective antigen surface concentration
#106Modified NK Cells and Uses Thereof
#107Combined organ and hematopoietic cells for transplantation tolerance of grafts
#108Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#109Compositions and methods related to engineered erythroid cells comprising IL-15
#110Combined organ and hematopoietic cells for transplantation tolerance of grafts
#111Combined organ and hematopoietic cells for transplantation tolerance of grafts
#112In vitro cell culture methods for beta-thalassemia using activin type II receptor ligand traps
#113Methods for expansion or depletion of t-regulatory cells
#114Shared neoantigens
#115Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#116Immunostimulatory compositions, particles, and uses related thereto
#117Therapeutic pooled blood apoptotic cell preparations and uses thereof
#118Compositions and methods related to engineered erythoid cells comprising 4-1BBL
#119Transduced T cells expressing human SSTR2 and application thereof
#120I domain chimeric antigen receptor specific to ICAM-1
#121Targeted therapeutic proteins
#122Methods and compositions for the treatment of melanoma
#123Compositions and methods for treatment of cancer
#124Methods for profiling the t cell repertoire
#125Multispecific and multifunctional molecules and uses thereof
#126Osteochondroreticular stem cells for bone and cartilage regeneration
#127Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
#128Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#129DIRECT EXPRESSION OF ANTIBODIES
#130Xenogenic normal tissue-derived vaccines for breaking the immune tolerance to tumor-associated, antigens
#131METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#132Anti-TLR4 antibodies and uses thereof
#133Method of generating antigen-specific immunological memory in a subject that rejects classical vaccines
#134Peptidic chimeric antigen receptor T cell switches and uses thereof
#135METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#136Method for protecting liver and a liver protecting agent
#137POLYVALENT ANTI-TUMOR FIBROBLAST VACCINE
#138PLACENTAL COMPOSITIONS FOR STIMULATION OF IMMUNITY TO PD-L1
#139Combined organ and hematopoietic cells for transplantation tolerance of HLA mismatched grafts
#140Cellular vaccine and method of inducing an immune response in a subject
#141AMPLIFICATION OF EPITOPE SPECIFIC PERSONALIZED ANTI-ANGIOGENIC IMMUNE RESPONSES
#142INHIBITION OF TUMOR ANGIOGENESIS BY CHECKPOINT INHIBITORS AND ACTIVE VACCINATION
#143Vaccination with immuno-isolated cells producing an immunomodulator
#144Compositions of GM-CSF and interleukin fusions for immune modulation and uses related thereto
#145Smallpox vaccine for cancer treatment
#146Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment
#147Iterative discovery of neoepitopes and adaptive immunotherapy and methods therefor
#148AUGMENTATION OF CANCER AND CANCER ENDOTHELIAL VACCINE IMMUNOGENICITY BY HISTONE DEACETYLASE INHIBITORS
#149POTENTIATING IMMUNE RESPONSE AGAINST CANCER
#150Method of obtaining cytolytic T cells by using mutant tumor epitopes
#151PLACENTAL COMPOSITIONS FOR STIMULATION OF IMMUNITY TO PD-L1
#152Methods and compositions for dosing in adoptive cell therapy
#153Targeted therapeutic proteins
#154Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#155IL-12 immunotherapy for cancer
#156Anti-inflammatory, skin-regenerative, whitening, antioxidant, or wound-healing composition containing culture medium of ADSC-T cells in which T-antigen is introduced into adipose-derived stem cell as active ingredient
#157Identification of CD8T cells that are CD161and/or IL18Rαand have rapid drug efflux capacity
#158Immune modulation
#159Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic Sendai virus
#160TARGET PEPTIDES FOR OVARIAN CANCER THERAPY AND DIAGNOSTICS
#161Methods for expansion or depletion of T-regulatory cells
#162Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#163Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
#164IMMUNOLOGICAL FUNCTION ENHANCING AGENT
#165Z cells activated by zinc finger-like protein and uses thereof in cancer treatment
#166Cellular vaccine and method of inducing an immune response in a subject
#167Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes
#168Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection
#169CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ tregs
#170Acellular pro-tolerogenic compositions and process for making same
#171Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases
#172Chimeric receptors and uses thereof in immune therapy
#173Epitope focusing by variable effective antigen surface concentration
#174IMMUNOSTIMULATORY COMPOSITIONS, PARTICLES, AND USES RELATED THERETO
#175Method of preparing apoptotic monocytes
#176Contraceptive vaccines for mammals
#177Soluble IGF receptor Fc fusion proteins and uses thereof
#178Activated Immunostimulatory Cell Composition and Uses Thereof
#179Anti-TLR4 antibodies and methods of use thereof
#180Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion
#181Combination therapy for a stable and long term engraftment
#182Adoptive cell therapy with young T cells
#183Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes
#184IMMUNOLOGICAL FUNCTION ENHANCING AGENT
#185Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders
#186Pre-Transplant Accommodated Organs Resistant To Anti-Donor Immunity
#187Abrogating HIV-1 Infection via Drug-Induced Reactivation of Apoptosis
#188Anti-TLR4 antibodies and methods of use thereof
#189Targeted therapeutic proteins
#190COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#191Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#192Artificial cells
#193Artificial cells
#194Artificial cells
#195METHODS OF ENHANCING T CELL RESPONSIVENESS
#196Novel Compositions and Uses Thereof
#197Compositions and methods for identifying antigens which elicit an immune response
#198Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
#199Method for diagnosing and/or treating tumor
#200CYTOKINE-COATED CELLS AND METHODS OF MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN
#201Compounds and methods for treatment and diagnosis of chlamydial infection
#202Artificial cells
#203Artificial cells
#204Artificial cells
#205Identifcation of CD8 T cells that are CD161and/or IL18Rαand have rapid drug efflux capacity
#206Adoptive cell therapy with young T cells
#207Expansion Of Renewable Stem Cell Populations
#208Pre-transplant accomodated organs resistant to anti-donor immunity
#209Modified leukotoxin gene and protein
#210Expansion of hematopoietic stem cells
#211Method for producing an antitumoral vaccine based on surface endothelial cell antigens
#212IL-12 immunotherapy for cancer
#213INDUCTION OF IMMUNOLOGICAL TOLERANCE
#214ACTIVATED DUAL SPECIFICITY LYMPHOCYTES AND THEIR METHODS OF USE
#215Prevention of Cancers by Immunization
#216Rheumatoid arthritis T cell vaccine
#217Materials and methods for immunizing against FIV infection
#218ANTI-ANGIOGENIC CELLULAR AGENT FOR CANCER THERAPY
#219DISPARATE SUICIDE CARRIER CELLS FOR TUMOR TARGETING OF PROMISCUOUS ONCOLYTIC VIRUSES
#220Method for production of antibody directed against cell membrane surface antigen epitope and assaying method
#221Compositions and methods for WT1 specific immunotherapy
#222METHOD OF PROLIFERATING LAK CELL
#223CELLULAR VACCINE
#224Multi-subtype FIV vaccines
#225Methods and Agents to Treat Autoimmune Diseases
#226Means and methods for generating a t cell against an antigen of interest
#227TARGETED THERAPEUTIC PROTEINS
#228Methods for treating autoimmune disease by inducing autoantigen-specific regulatory CD4+ T cells
#229Generation and isolation of antigen-specific T cells
#230COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#231COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#232Method for targeting lysosomal enzymes
#233COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#234COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#235INDUCTION OF IMMUNOLOGICAL TOLERANCE
#236Compounds and methods for treatment and diagnosis of chlamydial infection
#237ANTI-ANGIOGENIC CELLULAR AGENT FOR CANCER THERAPY
#238Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases
#239ANTI-ANGIOGENIC CELLULAR AGENT FOR CANCER THERAPY
#240Production And Therapeutic Uses Of Th1-Like Regulatory T Cells
#241COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#242COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#243COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#244COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
#245Multi-subtype FIV vaccines
#246Modified leukotoxin protein
#247Compositions and methods for identifying antigens which elicit an immune response
#248CD127 expression inversely correlates with FoxP3 and suppressive function of CD4Tregs
#249USE OF ALLOGENEIC EFFECTOR CELLS AND ANTI-CS1 ANTIBODIES FOR SELECTIVE KILLING OF MULTIPLE MYELOMA CELLS
#250DIFFERENT DENDRITIC CELL SUBSETS
#251Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#252Cytokine-coated cells and methods of modulating an immune response to an antigen
#253GENERATION AND ISOLATION OF ANTIGEN-SPECIFIC T CELLS
#254Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and use thereof
#255Compositions and methods of treatment
#256Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
#257Materials and methods for immunizing against FIV infection
#258Different dendritic cell subsets
#259Identification of new CD8 epitopes from HIV-1 proteins
#260Compounds and methods for treatment and diagnosis of chlamydial infection
#261Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance
#262Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
#263Methods of inducing differentiation in ex vivo expanded stem cells
#264Disease therapy using dying or dead cells
#265CD8 epitope from HIV-1 protein Vpu
#266Autogenous vaccine derived from one's own hypothalamus of the brain & kidney's via a process known as liquefaction
#267Methods of monitoring immunization
#268Method of obtaining immune cells from an animal
#269Interleukin-2 gene transferred lymphokine activated killer cells
#270Compounds and methods for treatment and diagnosis of chlamydial infection
#271Educated NKT cells and their uses in the treatment of immune-related disorders
#272Human hepatoma lines, methods for obtaining same and uses thereof
#273Expansion of renewable stem cell populations using modulators of PI 3-kinase
#274EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
#275Method of extended culture for antigen-specific cytotoxic lymphocytes
#276Materials and methods for immunizing against FIV infection
#277Induction of tolerance by apoptotic and/or necrotic cells
#278Expansion of renewable stem cell populations
#279Herpes simplex virus vaccine compositions and methods of production and use thereof